Holen Sie sich die Stockscreener-App
10.28
0.69%
0.07
Handel nachbörslich:
10.26
-0.02
-0.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.21
Offen:
$10.22
24-Stunden-Volumen:
38,874
Relative Volume:
0.53
Marktkapitalisierung:
$45.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.10M
KGV:
-1.0631
EPS:
-9.67
Netto-Cashflow:
$-36.82M
1W Leistung:
+15.51%
1M Leistung:
+3.63%
6M Leistung:
+7.15%
1J Leistung:
-43.52%
1-Tages-Spanne:
$10.09
$10.33
1-Wochen-Bereich:
$8.87
$10.41
52-Wochen-Spanne:
$5.3495
$20.67
Tempest Therapeutics Inc Stock (TPST) Company Profile
Firmenname
Tempest Therapeutics Inc
Sektor
Branche
Telefon
415-798-8589
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie TPST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.28 | 45.33M | 0 | -43.10M | -36.82M | -9.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-08 | Eingeleitet | Jefferies | Buy |
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
How Tempest Therapeutics Inc. stock benefits from global expansionEarnings Growth Report & Expert Verified Movement Alerts - newser.com
What moving averages say about Tempest Therapeutics Inc.Trade Analysis Summary & Verified Stock Trade Ideas - newser.com
Real time social sentiment graph for Tempest Therapeutics Inc.July 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Is Tempest Therapeutics Inc. still worth holding after the dipPortfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Applying chart zones and confluence areas to Tempest Therapeutics Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
Can Tempest Therapeutics Inc. stock maintain growth trajectoryJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
Should you wait for a breakout in Tempest Therapeutics Inc.July 2025 Update & AI Driven Stock Reports - newser.com
Published on: 2025-09-29 11:05:27 - earlytimes.in
Chart based analysis of Tempest Therapeutics Inc. trendsStop Loss & Stock Portfolio Risk Control - newser.com
Can a trend reversal in Tempest Therapeutics Inc. lead to recoveryGold Moves & Real-Time Chart Breakout Alerts - newser.com
Advanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight - GlobeNewswire Inc.
Will Tempest Therapeutics Inc. rebound enough to break evenJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Tempest Therapeutics Inc. stock prediction for this week2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Regression analysis insights on Tempest Therapeutics Inc. performanceMarket Risk Summary & Daily Entry Point Trade Alerts - newser.com
Identifying reversal signals in Tempest Therapeutics Inc.Quarterly Profit Report & Real-Time Stock Movement Alerts - newser.com
Risk adjusted return profile for Tempest Therapeutics Inc. analyzed2025 Historical Comparison & Growth Focused Investment Plans - newser.com
How to escape a deep drawdown in Tempest Therapeutics Inc.Weekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Is Tempest Therapeutics Inc. stock ready for a breakoutPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):